, Singapore
303 views
Photo courtesy of Tokio Marine Life Insurance Singapore Ltd.

Tokio Marine launches new cancer protection with multiple payouts

It boasts one of the highest potential payouts at 475%.

Tokio Marine Life Insurance Singapore Ltd. (TMLS) has launched a multiple payout innovative cancer protection plan with a potential payout of 475%, one of the highest in the market.

Called #go TotalProtect Cancer, the product covers early, intermediate, and advanced stages of cancer with claims payout of up to 150%. For advanced stage cancer, it has an additional two claims that are newly diagnosed or have spread, persisted or recurred.

ALSO READ: What an on-demand insurance product looks like

#go TotalProtect Cancer will also pay a monthly income for 25 months upon diagnosis of advance stage cancer. It also has additional payouts covering ICU admission, with a maximum payout of $36.26k (S$50k) and Cancer Supportive Therapy, subject to a maximum reimbursable amount of $3.63k (S$5k) per annum capped at $18.13k (S$25k).

As a launch bonus, TMLS will offer up to S$600 worth of CapitaLand Gift Vouchers to customers who purchase #go TotalProtect Cancer between 20 July 2022 and 30 September 2022, as part of the insurer’s 2022 Customer Campaign on #go TotalProtect Cancer.
 

Follow the link for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.